Vigor Peptides

Tirzepatide 60mg Bulk Pack

Tirzepatide is a dual-agonist peptide currently under investigation in preclinical and experimental research settings for its interaction with incretin-related receptor pathways and metabolic signaling systems.

Third-party lab tested with Certificate of Analysis (COA)
Supplied as a lyophilized powder (6 vials, 10mg each)
In stock and ready to ship

Note: This product is intended for laboratory research use only. Not for human consumption.

$595.00

Certificate of Analysis — Current Batch
View the most recent batch-specific COA and verification details for this product.
Historical COAs are available in the product gallery.
Purchase & earn 595 points!

Tirzepatide Peptide – Research Overview (60mg Bulk Pack / 6×10mg)

Tirzepatide peptide is a synthetic dual-agonist compound currently under investigation in preclinical and experimental research settings. As a GLP-1/GIP agonist, it is characterized by its interaction with two incretin-related receptor pathways: glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR).

This dual-agonist profile positions Tirzepatide as a research peptide for exploring coordinated signaling across multiple pathways within metabolic signaling systems and energy regulation models under controlled laboratory conditions.

Mechanism Profile in Research Settings

The Tirzepatide research peptide is studied for its interaction across two receptor pathways:

GLP-1R Interaction – Examined within incretin-related signaling systems in controlled research environments

GIPR Interaction – Investigated in relation to broader metabolic signaling pathways and receptor-level response mechanisms

As a GLP-1/GIP peptide, this dual-receptor activity supports evaluation of coordinated pathway interactions and signaling complexity in experimental models.

Research Context

Tirzepatide compound research is conducted in controlled laboratory settings focused on dual-pathway signaling systems and receptor interaction models. The Tirzepatide molecule is frequently utilized in comparative research involving both single-pathway and multi-receptor agonist compounds.

All referenced information reflects controlled research environments and is provided strictly for scientific and educational context.

Why Researchers Explore Tirzepatide

The Tirzepatide dual-agonist peptide is studied for its ability to engage multiple receptor systems simultaneously. This supports:

  • Dual-receptor interaction studies
  • Comparative pathway analysis
  • Experimental metabolic signaling models

The Tirzepatide 60mg bulk pack (6×10mg) format is designed for extended laboratory research, repeatable protocols, and multi-phase experimental workflows requiring consistent vial-to-vial performance.

Storage & Handling

Form: Lyophilized powder (6 vials, 10mg each)

Storage: -20°C in a moisture-free environment until reconstitution

Stability: Maintains integrity for extended periods when stored as directed

Use: For research purposes only. Not for human or veterinary use

Compliance Statement

This product is provided exclusively for laboratory research. Any discussion of research context is intended for educational purposes only. We do not recommend or endorse use in humans or animals. Researchers should follow all applicable regulations and ethical guidelines.

Quality & Verification

Each batch of Tirzepatide peptide undergoes comprehensive third-party analytical testing to verify identity, purity, and quantity.

Additional testing includes:

  • Endotoxin analysis (LAL)
  • Sterility-related testing protocols

All testing is performed to support research-use characterization and batch consistency. A corresponding Certificate of Analysis (COA) is provided for each lot.

All vials in this pack correspond to the same tested lot to ensure consistency across the full batch.

Each batch also includes a fully traceable lab report hosted within the laboratory’s LIMS (Laboratory Information Management System), allowing independent verification of test results directly through the lab’s reporting system.

Ordering & Availability

Laboratories seeking to get Tirzepatide online bulk or buy Tirzepatide online can review current batch availability, third-party testing documentation, and transparent pricing directly on this page.

For those evaluating bulk Tirzepatide peptide options, the 60mg pack provides a balanced format between smaller multi-packs and larger bulk configurations, while maintaining consistent quality and verification standards.

Whether conducting repeat studies or extended research workflows, this Tirzepatide bulk format supports scalable laboratory research requirements.

Frequently Asked Questions

Q: What is included in the Tirzepatide 60mg bulk pack?
A: This product includes six 10mg vials (60mg total), each supported by third-party testing and a matching COA.

Q: Is bulk Tirzepatide tested and verified?
A: Yes. Each batch undergoes third-party analytical testing to confirm identity, purity, and quantity.

Q: Why choose the 60mg bulk pack?
A: This format supports extended research applications while offering improved cost efficiency per vial compared to smaller pack sizes.

Summary

Tirzepatide peptide is a dual-agonist research compound characterized by its interaction with GLP-1R and GIPR receptor pathways. This dual-receptor profile supports the study of coordinated signaling across metabolic pathways and energy regulation systems in controlled laboratory environments.

The Tirzepatide 60mg bulk pack (6×10mg) is supplied as a set of lyophilized vials and supported by third-party analytical testing, including verification of identity, purity, and quantity, with a corresponding Certificate of Analysis (COA) for each batch.

Other Formats Available

The 60mg bulk bundle provides a reduced per-vial cost for mid-scale projects. For other options, see:

Introduction: Tirzepatide Peptide for Research

Tirzepatide peptide is a synthetic dual-agonist molecule developed for use in controlled laboratory environments. As a GLP-1/GIP receptor agonist, it engages two incretin-related signaling pathways, providing a model for studying multi-pathway interactions within metabolic signaling systems and energy regulation frameworks.

Researchers seeking to get Tirzepatide online bulk often select mid-range multi-pack formats for consistency across experimental conditions. The Tirzepatide 60mg bulk pack includes six lyophilized vials and is supported by third-party testing with a batch-matched Certificate of Analysis (COA) for research-use verification.

Tirzepatide Peptide – Research Overview

Tirzepatide belongs to a class of incretin-based research peptides characterized by dual-receptor interaction:

GLP-1R (glucagon-like peptide-1 receptor) – Studied within incretin-related signaling pathways in controlled research environments

GIPR (glucose-dependent insulinotropic polypeptide receptor) – Investigated in relation to broader metabolic signaling systems

As a GLP-1/GIP peptide, this dual-agonist structure supports the study of coordinated receptor activity and pathway interaction in experimental models.

Synonyms commonly referenced in research literature include:

  • Tirzepatide peptide
  • Tirzepatide dual-agonist
  • Tirzepatide research peptide
  • GLP-1/GIP agonist

Mechanism Profile in Research Models

GLP-1R Interaction

GLP-1 receptor interaction is examined within incretin-related signaling systems and pathway modeling in controlled environments.

GIPR Interaction

GIP receptor interaction is studied in relation to metabolic signaling pathways and receptor-level response mechanisms.

Dual-Agonist Framework

By engaging both receptor pathways simultaneously, Tirzepatide provides a framework for evaluating multi-pathway signaling and receptor interaction complexity. Comparative research may evaluate this dual-agonist profile alongside single-pathway compounds.

Research Context

Tirzepatide compound research is conducted in controlled laboratory settings focused on receptor interaction models and multi-pathway signaling systems. The Tirzepatide molecule is commonly utilized in comparative research involving both single-pathway and multi-receptor agonist compounds.

All referenced information reflects controlled research environments and is provided strictly for scientific and educational context.

Why Researchers Explore Tirzepatide Peptide

The Tirzepatide dual-agonist peptide is studied for its ability to engage multiple receptor systems simultaneously. This supports:

  • Dual-receptor interaction studies
  • Comparative pathway analysis
  • Experimental metabolic signaling models

The Tirzepatide 60mg bulk pack format supports repeatable experiments, controlled comparisons, and extended laboratory research applications requiring consistent compound performance.

Buying Tirzepatide Online (Bulk Format)

Laboratories evaluating where to get Tirzepatide online can utilize bulk formats to support extended research workflows.

  • Tirzepatide 60mg Bulk Pack (6×10mg) – Suitable for mid-scale research applications and multi-phase experimental studies

Additional formats may be available to support varying research needs.

Tirzepatide Price and Value

Tirzepatide pricing may vary depending on format and supplier standards. Bulk configurations provide improved cost efficiency per vial while maintaining consistent quality standards.

Each vial includes:

  • Third-party analytical testing
  • Batch-matched Certificate of Analysis (COA)
  • Secure, stability-conscious packaging
  • Lyophilized powder format

Tirzepatide Powder: Storage and Handling

Form
Lyophilized powder (6 vials, 10mg each)

Storage
Store at -20°C in a dry, moisture-free environment until reconstitution

Stability
Maintains integrity for extended periods when stored as directed

Handling
Reconstitution should follow standard laboratory protocols

Use
For research purposes only. Not for human or veterinary use

Technical Details

Name: Tirzepatide peptide
Form: Lyophilized powder
Quantity: 6 vials (10mg each, 60mg total)

Synonyms:
Tirzepatide peptide
Tirzepatide research peptide
Tirzepatide dual-agonist
GLP-1/GIP agonist

Applications:
Investigated in metabolic signaling and receptor interaction research models

Testing:
Third-party tested for identity, purity, and quantity
Endotoxin analysis (LAL)
Sterility-related testing protocols

Availability:
Bulk pack format

Compliance Statement

This product is offered strictly for laboratory research use only (RUO). It is not intended for human consumption, medical use, or diagnostic applications. Any discussion of research context is provided solely for educational purposes. Researchers are expected to follow all applicable regulations, ethical guidelines, and laboratory best practices.

Conclusion: Tirzepatide 60mg Bulk Pack for Laboratory Research

Tirzepatide peptide is a dual-agonist research compound characterized by its interaction with GLP-1R and GIPR receptor pathways. This structure supports the study of coordinated signaling across metabolic systems and multi-pathway models in controlled laboratory environments.

The Tirzepatide 60mg bulk pack (6×10mg) provides multiple lyophilized vials supported by third-party analytical testing, including verification of identity, purity, and quantity, with a corresponding Certificate of Analysis (COA) for each batch.

Researchers can buy Tirzepatide online in a format designed to support consistent, repeatable, and scalable laboratory research applications.

Research use disclaimer
Scroll to Top